he Prevalence of Erectile Dysfunction in Post-Treatment Colorectal Cancer Patients and Their Interests in Seeking Treatment: A Cross-Sectional Survey

The Prevalence of Erectile Dysfunction in Post-Treatment Colorectal Cancer Patients and Their Interests in Seeking Treatment: A Cross-Sectional Survey in the West-Midlands.

Ellis R, Smith A, Wilson S, Warmington S, Ismail T.

School of Medicine, College of Medical & Dental Sciences, University of Birmingham, Birmingham, UK.

ABSTRACT Introduction. Erectile dysfunction (ED) is a recognized complication of colorectal cancer treatment, particularly if surgery is below the recto-sigmoid junction (RSJ), and is an important quality-of-life issue. Previous studies have generated inconsistent prevalence estimates. Aim. We aimed to establish the prevalence of ED in postsurgery colorectal cancer patients and to establish what proportion wished to seek treatment. Main Outcome Measures. Questionnaire: sociodemographics, treatment methods, International Index of Erectile Function (IIEF)-5 questionnaire (validated tool to assess erectile function): score of <21 p =" 0.002)," p =" 0.007)," p =" 0.014)." p =" 0.002)">

PMID: 19694923 [PubMed - as supplied by publisher]